Modern Fertility AMH testing: what 95th vs 5th percentile means (2026)

What AMH actually measures

Anti-Mullerian hormone (AMH) is produced by granulosa cells of small growing follicles in the ovary. The level in the bloodstream correlates with the number of small follicles present at any given time, which serves as a proxy for ovarian reserve — the remaining pool of follicles available for future ovulation.

AMH is a measure of ovarian reserve quantity, not quality. Two women with identical AMH values can have very different fertility outcomes because egg quality (driven primarily by age) determines whether a given egg can produce a viable pregnancy.

The test became widely available through both clinical labs and at-home companies (Modern Fertility, LetsGetChecked, others) over the past decade. At-home AMH testing has democratized access but also produced significant misinterpretation, because percentile-only reporting and absent clinical context distort what the value means.

Why percentile reporting is misleading

Modern Fertility and similar at-home services typically report AMH as a percentile compared to other women in the same age range. A 'low' result might be at the 5th percentile for age 30; a 'high' result might be at the 95th.

Two problems with percentile-only reporting: First, the percentile is descriptive (where you fall in the distribution), not prognostic (what it predicts about pregnancy outcomes). A 5th-percentile AMH at age 25 is concerning; a 5th-percentile AMH at age 42 is expected and may not change the clinical picture.

Second, normal ranges for AMH are wide. AMH values from 0.5 ng/mL to 4.0 ng/mL are all within normal at various ages. The clinical implication of being at the 50th percentile vs the 20th percentile is often negligible — both are normal and predict similar fertility outcomes.

The clinically useful number is the absolute AMH value in ng/mL (or pmol/L), interpreted alongside age, cycle regularity, and other reproductive markers. Percentile alone produces anxiety without actionable information.

What low AMH means (and doesn't)

Low AMH (commonly defined as <1.0 ng/mL, varying by lab) indicates diminished ovarian reserve. It correlates with fewer eggs retrieved during IVF cycles and earlier expected menopause. It does NOT predict natural fertility well — many women with low AMH conceive naturally without difficulty, and many with normal AMH have unexplained infertility.

What low AMH cannot tell you: whether you can conceive naturally this cycle; whether your eggs are healthy; whether you have an underlying cause beyond age-related decline; how quickly your reserve will decline going forward.

What low AMH usefully informs: planning around fertility timing if you're delaying pregnancy; estimated response to ovarian stimulation if you pursue IVF or egg freezing; whether to seek a fertility evaluation sooner rather than later if trying to conceive.

The realistic action for low AMH in someone planning future pregnancy: consultation with a reproductive endocrinologist within 3-6 months. Not because the AMH itself is an emergency, but because the comprehensive evaluation includes other tests (antral follicle count, FSH, partner evaluation) that together provide a clearer clinical picture.

What high AMH means (and doesn't)

High AMH (>4.0-5.0 ng/mL in most age groups) most commonly reflects polycystic ovary syndrome. PCOS produces an excess of small antral follicles that don't progress to ovulation, and these follicles produce AMH. Approximately 80% of PCOS patients have elevated AMH.

High AMH outside of PCOS is uncommon but can occur. Some women have constitutionally higher reserves without PCOS clinical features. Some PCOS phenotypes are diagnosed primarily on AMH and ultrasound without the classic hyperandrogenism.

What high AMH doesn't mean: abundant fertility or easy conception. PCOS itself is one of the most common causes of infertility because anovulation prevents the egg from being released regardless of how many follicles are present. A patient with AMH at the 95th percentile and PCOS may have more trouble conceiving than a patient with average AMH and regular cycles.

If you receive a high AMH result, the next clinical step is evaluating for PCOS: cycle regularity assessment, hirsutism/acne evaluation, free testosterone and SHBG, and ovarian ultrasound. PCOS diagnosis affects management more meaningfully than the high AMH itself.

AMH and egg freezing decisions

Egg freezing decisions are commonly influenced by AMH results — sometimes appropriately, often not. The relevant clinical question for egg freezing is how many eggs can realistically be retrieved per stimulation cycle, which depends on AMH and antral follicle count together.

A patient with AMH of 0.5 ng/mL might retrieve 3-5 eggs per cycle on average; a patient with AMH of 3.0 ng/mL might retrieve 12-18 eggs per cycle. The egg freezing target most clinics aim for is 20-30 eggs frozen for a single future-pregnancy attempt, which translates to 1-2 cycles for the higher-AMH patient and 4-6 cycles for the lower-AMH patient.

The decision to freeze eggs based on a low AMH result alone is one of the more common misuses of at-home testing. The realistic process is: receive the AMH result, consult a reproductive endocrinologist for comprehensive evaluation including antral follicle count, discuss cost and outcome expectations, then make the decision. Acting on an isolated AMH percentile from an at-home test can lead to expensive decisions without adequate information.

Realistic use of at-home AMH testing

At-home AMH testing is most useful as an entry point to fertility conversation, not a standalone clinical decision-making tool. The reasonable use case: a woman in her early to mid 30s considering future pregnancy timing wants a directional sense of her reserve. The result, combined with age and family history, informs whether to seek a fertility evaluation earlier or later.

It's less useful when acted on alone. Decisions about egg freezing, fertility treatment, or pregnancy timing should incorporate at-home AMH as one data point among several, not as the deciding factor.

If you have an at-home AMH result you're uncertain about: ask for the absolute value in ng/mL (not just the percentile), look up your age-adjusted reference range, and bring the result to a primary care physician or reproductive endocrinologist for clinical context. The 30-minute conversation often provides more value than the test itself.